Detalhe da pesquisa
1.
Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity.
Gynecol Oncol
; 183: 61-67, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38518529
2.
Life Experience of Survivors of Gynecologic Cancers: A Survey Conducted in Italy.
Oncology (Williston Park)
; 38(1): 15-19, 2024 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300531
3.
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study.
Gynecol Oncol
; 175: 182-189, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37355448
4.
Homologous Recombination Deficiency (HRD) Scoring, by Means of Two Different Shallow Whole-Genome Sequencing Pipelines (sWGS), in Ovarian Cancer Patients: A Comparison with Myriad MyChoice Assay.
Int J Mol Sci
; 24(23)2023 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38069422
5.
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study.
Breast Cancer Res
; 24(1): 71, 2022 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36307826
6.
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study.
Int J Gynecol Cancer
; 31(7): 1031-1036, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33990353
7.
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome.
Gynecol Oncol
; 156(1): 38-44, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31699415
8.
Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study.
Eur J Cancer
; 203: 114039, 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598922
9.
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society.
Tumori
; 109(5): 490-495, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36609207
10.
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)-Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors-A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study.
Cancers (Basel)
; 16(1)2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38201470
11.
Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial.
Eur Urol
; 83(1): 82-89, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36216658
12.
Appropriate management of cutaneous adverse events maximizes compliance with sorafenib treatment: a single-center experience.
Future Oncol
; 8(5): 609-15, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22646774
13.
Immune-checkpoint inhibitors from cancer to COVID19: A promising avenue for the treatment of patients with COVID19 (Review).
Int J Oncol
; 58(2): 145-157, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33491759
14.
A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review).
Int J Oncol
; 59(1)2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34132354
15.
Correction: Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial.
PLoS One
; 16(8): e0256944, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34437624
16.
Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?
Cancers (Basel)
; 12(8)2020 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32785162
17.
Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial.
PLoS One
; 15(10): e0239803, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33031478
18.
Quality of Life in Women Diagnosed with Breast Cancer after a 12-Month Treatment of Lifestyle Modifications.
Nutrients
; 13(1)2020 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33396551
19.
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status.
J Ovarian Res
; 12(1): 9, 2019 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30691488
20.
Eribulin mesylate use as third-line therapy in patients with metastatic breast cancer (VESPRY): a prospective, multicentre, observational study.
Ther Adv Med Oncol
; 11: 1758835919895755, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31903098